original ) (raw )Expression of the fusion (F) protein of human respiratory syncytial virus from recombinant vaccinia virus vectors
Gail Wertz , L. Andrew Ball
Virus Research, 1985
View PDFchevron_right
Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine
Julie Fischer
Journal of General Virology, 2001
View PDFchevron_right
Expression oftheFusion Protein ofHumanRespiratory Syncytial VirusfromRecombinant Vaccinia VirusVectors and Protection ofVaccinated Mice
L. Andrew Ball
1987
View PDFchevron_right
Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus
L. Andrew Ball
Journal of …, 1987
View PDFchevron_right
Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors
L. Andrew Ball
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Single Immunization of a Vaccine Vectored by a Novel Recombinant Vaccinia Virus Affords Effective Protection Against Respiratory Syncytial Virus Infection in Cotton Rats
David Safronetz
Frontiers in Immunology, 2021
View PDFchevron_right
Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G …
Mathias Uhlén
Virology, 1997
View PDFchevron_right
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants
L. Andrew Ball
The Journal of Immunology
View PDFchevron_right
Recombinant Human Respiratory Syncytial Virus (RSV) from cDNA and Construction of Subgroup A and B Chimeric RSV
Martin Bryant
Virology, 1998
View PDFchevron_right
Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge
L. Andrew Ball
Journal of Virology, 1986
View PDFchevron_right
Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein
Sundararajan Venkatesan
Proceedings of the National Academy of Sciences, 1986
View PDFchevron_right
Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G Protein Fragment
Thien Nguyen
Virology, 1997
View PDFchevron_right
Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection
José López
Journal of General Virology, 1996
View PDFchevron_right
Expression and characterization of a multivalent human respiratory syncytial virus protein
Gerold Willing
Molecular Biology, 2010
View PDFchevron_right
Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
Bettina Tippler , Vladimir Temchura
Journal of Virology, 2009
View PDFchevron_right
Development of Novel Recombinant DNA Vaccine Candidates to Human Respiratory Syncytial Viruses
Mohamed Ali
View PDFchevron_right
Characterization of Monoclonal Antibodies Raised against Recombinant Respiratory Syncytial Virus Nucleocapsid (N) Protein: Identification of a Region in the Carboxy Terminus of N Involved in the Interaction with P Protein
Jillian Murray
Virology, 2001
View PDFchevron_right
Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells
Mario Amacker
Vaccine, 2009
View PDFchevron_right
Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro
Qingzhong Yu
Journal of Virology, 2004
View PDFchevron_right
Respiratory Syncytial Virus: Current Progress in Vaccine Development
Bart Jones , Sherri Surman
Viruses, 2013
View PDFchevron_right
Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
Ultan Power
FEMS Immunology & Medical Microbiology, 2000
View PDFchevron_right
Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B
Sateesh Krishnamurthy , Toru Takimoto
Vaccine, 2007
View PDFchevron_right
Construction of adenoviral vectors expressing F and G glycoproteins of human respiratory syncytial virus (HRSV)
Armando Ventura
Brazilian Journal of Microbiology, 2004
View PDFchevron_right
Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus
James Crowe
Journal of virology, 1995
View PDFchevron_right
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies
Mark Connors
Journal of Virology, 1992
View PDFchevron_right
Genetic Vaccine for Respiratory Syncytial Virus Provides Protection Without Disease Potentiation
david rangel
Molecular Therapy, 2014
View PDFchevron_right
Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity
Marlies Boeren
Virus Research, 2019
View PDFchevron_right
The respiratory syncytial virus subgroup B attachment glycoprotein: analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge
Gail Wertz
Virology, 1990
View PDFchevron_right
Respiratory Syncytial Virus Recombinant F Protein (Residues 255–278) Induces a Helper T Cell Type 1 Immune Response in Mice
Christina Carter
Viral Immunology, 2007
View PDFchevron_right
Isolation anti characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus
James Crowe
VACCINE, 1995
View PDFchevron_right
Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication
Qingzhong Yu
Journal of Virology, 1995
View PDFchevron_right
Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein
Fu-Shi Quan
PLOS ONE, 2018
View PDFchevron_right
Human Vaccines & Immunotherapeutics Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency
Haitham Amer
View PDFchevron_right